A consistent UK approach has been taken to decision-making on access to these new COVID-19 therapeutics, including novel oral antivirals that can be used at the earliest stage of infection. The Rapid C-19 Oversight Group, whose membership includes the Scottish Medicines Consortium (SMC), leads on horizon scanning and the provision of advice on whether the c...